Botanix News Hub
Welcome to our home for news – the latest headlines, all in one place. Click through to view a selection of our media coverage, industry news, videos and more.
Welcome to our home for news – the latest headlines, all in one place. Click through to view a selection of our media coverage, industry news, videos and more.
Botanix reshuffles business priorities
/in Featured, Latest News /by administratorBotanix Pharmaceuticals Limited (ASX: BOT) today provided investors with an update on its suite of cannabis-derived clinical trials that target dermatological and antimicrobial conditions. In addition to this, the company has provided its roadmap, outlining how Botanix will be moving forward amid the COVID-19 crisis.
Click HERE to read the article on The Green Fund.
Botanix Pharmaceuticals (ASX:BOT) launches Phase 2 BTX 1801 study for SSIs
/in Latest News /by administratorBotanix Pharmaceuticals plans new study into antimicrobial platform and BTX 1801
/in Latest News /by administratorBotanix’s cannabis drug kills bacteria in minutes
/in Latest News /by administratorBotanix achieved significant results with Acne drug
/in Latest News /by administratorAustralia is a leader in cannabis biotechs – here are three stocks that could be poised for growth
/in Latest News /by administrator